Which clinical history findings are used to guide therapy for pediatric tinea versicolor?

Updated: Jan 27, 2020
  • Author: Lyubomir A Dourmishev, MD, PhD; Chief Editor: Dirk M Elston, MD  more...
  • Print

Questioning the patient with tinea versicolor about skin or systemic diseases, current therapy, and drug allergies provides guidance in selecting an appropriate therapy. The following are factors that may be used to guide therapy:

  • Other diseases, including renal disease, hepatic disease, and endocrine disease (eg, diabetes mellitus)

  • History of HIV or other immunocompromising disorder, which can increase the severity of tinea versicolor

  • Other skin disorders, including personal or family history of atopy or other eczematous conditions

  • Current or recent topical or systemic therapy

  • Drug allergies

  • Seasonal variations in skin color

  • Use of some body oils, which may supply additional nutrients to the M furfur

  • Sweat associated with exercise, which may contribute to disease development and recurrence

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!